Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAE cream in mild to moderate atopic dermatitis
NCT07113366Phase 1Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- May 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ficus awkeotsang makino extract in atopic dermatitis (AD) (3 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Proportion of Participants Achieving Investigator's Global Assessment Success at Day 28. Started May 2024; status: completed.
02
Drugs
ficus awkeotsang makino extract
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07113366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113366.